Contact
searchSearch
HMP Global

Volume 14 - Issue 5 - May 2006

Issues in Dermatology
iPLEDGE to Use the New FDA Program — But Only Because I Have To
09/04/2008
Oral isotretinoin (Accutane, Amnesteem, Claravis, Sotret) has been available in the United States for treatment of cystic and nodular acne vulgaris for more than 20 years. This medication truly revolutionized our specialty. However, it has...
Oral isotretinoin (Accutane, Amnesteem, Claravis, Sotret) has been available in the United States for treatment of cystic and nodular acne vulgaris for more than 20 years. This medication truly revolutionized our specialty. However, it has...
Oral isotretinoin (Accutane,...
09/04/2008
The Dermatologist

Current Issue

October 2024
Volume 32
Issue 7
Current Issue
Issue Archive

Popular Articles

combined clinics - handshake
Conference Coverage
Combined Clinics – Treating Patients as a Whole
04/22/2022
Dr Joseph F Merola, MD, MMSc and Dr Alexis Ogdie, MD, MSCE got together to discuss combined clinics touched base on “accessing the role of interdisciplinary care in optimizing disease outcomes and then understanding how combined approaches to...
Dr Joseph F Merola, MD, MMSc and Dr Alexis Ogdie, MD, MSCE got together to discuss combined clinics touched base on “accessing the role of interdisciplinary care in optimizing disease outcomes and then understanding how combined approaches to...
Dr Joseph F Merola, MD, MMSc and...
04/22/2022
The Dermatologist
The Price of Developing New Drugs
09/04/2008
The average cost of developing a new prescription drug is $897 million, almost four times the cost in the early 1990s, according to a study by the Tufts Center for the Study of Drug Development, Bloomberg/Bern Record reports. Results of the...
The average cost of developing a new prescription drug is $897 million, almost four times the cost in the early 1990s, according to a study by the Tufts Center for the Study of Drug Development, Bloomberg/Bern Record reports. Results of the...
The average cost of developing...
09/04/2008
The Dermatologist
Brett King, MD, PhD
Conference Coverage
The Pathogenesis and Treatment of Alopecia Areata
05/12/2022
During his session presented at Dermatology Week 2022, Brett King, MD, PhD, discussed the lack of effective treatment for alopecia areata, and recent data on utilizing JAK inhibitors.
During his session presented at Dermatology Week 2022, Brett King, MD, PhD, discussed the lack of effective treatment for alopecia areata, and recent data on utilizing JAK inhibitors.
During his session presented at...
05/12/2022
The Dermatologist
Wealth of Promising Treatments
09/04/2008
E ach year, you and your colleagues will diagnose more than 150,000 patients with new cases of psoriasis — 20,000 of these patients will be children, according to the American Academy of Dermatology (AAD). For the more than 7 million...
E ach year, you and your colleagues will diagnose more than 150,000 patients with new cases of psoriasis — 20,000 of these patients will be children, according to the American Academy of Dermatology (AAD). For the more than 7 million...
E ach year, you and your...
09/04/2008
The Dermatologist
News
Risankizumab Shows Comparable Safety and Efficacy Profiles in Patients With Psoriasis
06/08/2022
Researchers aimed to perform a real-life study to compare indirect efficacy and safety of anti-IL23s.
Researchers aimed to perform a real-life study to compare indirect efficacy and safety of anti-IL23s.
Researchers aimed to perform a...
06/08/2022
The Dermatologist

Subscribe

The Dermatologist Newsletter

Latest Quizzes and Trivia

Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies...
11/11/2024
The Dermatologist
Illustration of a T cell
QUIZ
Test Your Knowledge: The Immunology of Alopecia Areata
11/04/2024
11/04/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
Brain
Quiz
Barriers to Mental Health Support
10/10/2024
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
AD
Quiz
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein...
09/15/2024
The Dermatologist
psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist

May 2006 Issue 5

View Issue Archive
Editorial Staff

VP, HMP Omnimedia: Kara Rosania
President, HMP Global: David DePinho
Senior Managing Editor: Coleen M.F. Stern
Associate Digital Editor: Jessica Garlewicz
Associate Editor: Riya Gandhi

Editorial Correspondence

Email: dermeditor@hmpglobal.com

Phone: (610) 560-0500
Fax: (866) 800-4236

Mailing Address
HMP Global
70E Swedesford Rd, Suite 100
Malvern, PA 19355

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use